Esomeprazole Magnesium Capsule, Delayed Release
NDC Package 49483-718-41
Package Information
Esomeprazole Magnesium capsules is usestreats frequent heartburn (occurs 2 or moredays a week) not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect. This formulation utilizes a capsule, delayed release delivery system. Marketed by Time Cap Laboratories, Inc., this product is identified by NDC 49483-718 and is authorized under FDA application ANDA217264.
Identification & Billing
- RxCUI: 606726 - esomeprazole magnesium 20 MG Delayed Release Oral Capsule
- RxCUI: 606726 - esomeprazole 20 MG Delayed Release Oral Capsule
- RxCUI: 606726 - esomeprazole 20 MG (as esomeprazole magnesium dihydrate 22 MG) Delayed Release Oral Capsule
- RxCUI: 606726 - esomeprazole 20 MG (as esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49483 - Time Cap Laboratories, Inc.
- 49483-718 - Esomeprazole Magnesium
- 49483-718-41 - 3 BOTTLE in 1 CARTON / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
- 49483-718 - Esomeprazole Magnesium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49483-718-41 identifies a specific commercial package of 3 bottle in 1 carton / 14 capsule, delayed release in 1 bottle of Esomeprazole Magnesium, a human over the counter drug labeled by Time Cap Laboratories, Inc.. This capsule, delayed release is formulated for oral use and contains esomeprazole magnesium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Time Cap Laboratories, Inc. on November 14, 2023. The current certification is valid through December 31, 2026.
How is this Time Cap Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49483071841. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.